{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:26:20Z","timestamp":1793791580858,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijcrp.2026.200697","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:39:18Z","timestamp":1786664358000},"page":"200697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world patterns in lipid profile testing and lipid-lowering therapy in hospitalized patients: The Jurasz Lipid Study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-2950","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Ostrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Ratajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Zi\u00f3\u0142kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Fabiszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudyna","family":"Grzelakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Laskowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Niezgoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Obo\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Umi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Chlebus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliano P.","family":"Navarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Szarpak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Grymuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Konarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Topolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2026.200697_bib1","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200697_bib2","first-page":"642","article-title":"Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study","volume":"126","author":"Paj\u0105k","year":"2016","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200697_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5603\/KP.2016.0029","article-title":"Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey","volume":"74","author":"Zdrojewski","year":"2016","journal-title":"Kardiol. Pol."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200697_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.5114\/aoms\/141941","article-title":"PoLA\/CFPiP\/PCS\/PSLD\/PSD\/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021","volume":"17","author":"Banach","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"41","key":"10.1016\/j.ijcrp.2026.200697_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"46","key":"10.1016\/j.ijcrp.2026.200697_bib6","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200697_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ehjcvp\/pvz079","article-title":"An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC working group on cardiovascular pharmacotherapy: barriers to be overcome","volume":"6","author":"Drexel","year":"2020","journal-title":"Eur. Heart. J. Cardiovasc. Pharmacother"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200697_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006460","article-title":"Lipid testing and Statin dosing after acute myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200697_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2014.09.088","article-title":"Underutilization of high-intensity Statin therapy after hospitalization for coronary heart disease","volume":"65","author":"Rosenson","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200697_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68915-1","article-title":"Medication adherence and its determinants in patients after myocardial infarction","volume":"10","author":"Pietrzykowski","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200697_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal Statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200697_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","article-title":"Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction","volume":"27","author":"Gislason","year":"2006","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200697_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5603\/mrj.107066","article-title":"Cross-sectional analysis of lipid profile of patients treated at a multi-specialist clinical center \u2014 rationale and study protocol for the Jurasz lipid study (JLS)","author":"Ratajczak","year":"2025","journal-title":"Med. Res. J."},{"key":"10.1016\/j.ijcrp.2026.200697_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026551","article-title":"Lipid-lowering trials are not representative of patients managed in clinical practice: a systematic review and meta-analysis of exclusion criteria","volume":"12","author":"Aeschbacher-Germann","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2026.200697_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjc.2025.05.006","article-title":"Prevalence, incidence, and patterns of lipid-lowering treatment in Greece based on real-world nationwide data on 8,535,780 adults","author":"Mathioudakis","year":"2025","journal-title":"Hellenic J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200697_bib16","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3390\/jcm12072738","article-title":"Determinants of lipid parameters in patients without diagnosed cardiovascular disease-results of the Polish arm of the EUROASPIRE V survey","author":"Ratajczak","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcrp.2026.200697_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283369","article-title":"Value of the clinical pharmacist interventions in the application of the American college of cardiology (ACC\/AHA) 2018 guideline for cholesterol management","volume":"18","author":"AlAhmad","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcrp.2026.200697_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12944-024-02221-x","article-title":"Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021-2022","volume":"23","author":"Capece","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"84","key":"10.1016\/j.ijcrp.2026.200697_bib19","first-page":"1869","article-title":"2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American college of cardiology\/american Heart association joint committee on clinical practice guidelines","author":"Writing","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"44","key":"10.1016\/j.ijcrp.2026.200697_bib20","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200697_bib21","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873221100032","article-title":"European stroke organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack","author":"Dawson","year":"2022","journal-title":"Eur. Stroke. J."},{"issue":"41","key":"10.1016\/j.ijcrp.2026.200697_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/STROKEAHA.109.567693","article-title":"Frequency and determinants of lipid testing in ischemic stroke and transient ischemic attack: findings from get with the guidelines-stroke","author":"Smith","year":"2010","journal-title":"Stroke"},{"issue":"15","key":"10.1016\/j.ijcrp.2026.200697_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jcm15010026","article-title":"Association between lipid-lowering therapy and differences in the distribution of LDL-C, apoB and non-HDL-C","author":"Zi\u00f3\u0142kowski","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcrp.2026.200697_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12944-025-02712-5","article-title":"Lipid profile and the variables associated with control of selected lipid parameters in patients of a large multi-specialist hospital in Poland - the Jurasz Lipid Study (JLS)","volume":"24","author":"Zi\u00f3\u0142kowski","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"23","key":"10.1016\/j.ijcrp.2026.200697_bib25","article-title":"Real-world prescribing in accordance to ACC\/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD: Real-world prescribing for lipid-lowering therapy","author":"Arnold","year":"2025","journal-title":"Am. J. Prev. Cardiol."},{"issue":"28","key":"10.1016\/j.ijcrp.2026.200697_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-Wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","author":"Ray","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200697_bib27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2026.200697_bib28","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200697_bib29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200697_bib30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200697_bib31","article-title":"Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance","author":"Laufs","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"85","key":"10.1016\/j.ijcrp.2026.200697_bib32","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","author":"Rao","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcrp.2026.200697_bib33","article-title":"Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database","author":"Terentes-Printzios","year":"2024","journal-title":"Int. J. Cardiol. Cardiovasc. Risk. Prev."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:38:05Z","timestamp":1793788685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S2772487526001273"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200697","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world patterns in lipid profile testing and lipid-lowering therapy in hospitalized patients: The Jurasz Lipid Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200697"}}